Lubricin Peptide Explained
Imagine your joints as door hinges that need to slide smoothly thousands of times a day. Lubricin is basically your body's natural grease for those hinges. It's a slippery protein your joints naturally produce to keep cartilage surfaces gliding against each other without wearing out. People use synthetic versions of it because as joints age or get damaged, your body doesn't make enough of this lubricant anymore, leading to arthritis and pain.
Here's how it actually works: lubricin sticks to your cartilage surfaces like a thin protective coating, similar to how wax makes a floor slippery. This coating is especially important when you're moving under pressure—when your joint is bearing weight but moving slowly, that's when friction becomes dangerous. Without enough lubricin, cartilage surfaces start grinding against each other, damaging the cells underneath and triggering the downward spiral of arthritis. Beyond just lubrication, lubricin also calms down inflammation in your joint space and prevents scar tissue buildup. Scientists are now injecting synthetic lubricin directly into damaged joints to restore what your body isn't making anymore, essentially giving your aging hinges fresh grease. Early studies show it actually protects cartilage from further damage rather than just masking pain.
Dosage Information
Typical Dose
Research/clinical trial doses: 3-9 mg intra-articular injection
Frequency
Monthly intra-articular injections in trial protocols
Administration
Intra-articular injection by physician
Half-Life
~12 hours
estimatedNotes
Recombinant lubricin (rhPRG4) is in Phase 2 clinical trials for knee OA. Not commercially available for OA. FDA-approved as OcuLieve for dry eye disease (different indication). This entry documents its research significance for joint lubrication.
Why this matters
Joint lubrication peptide; intra-articular delivery for local action.
Protocol cycle
Dose Calculator
Calculate your draw amount for an insulin syringe (U-100)
Concentration: 2,500 mcg/mL
Sign in to save your reconstitution settings for this peptide
Draw to the
120
unit mark
Draw 120 units for your 3000mcg dose of Lubricin Peptide
This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.
Where does Lubricin Peptide sit?
See how this peptide compares across all 150 peptides in our database.
Evidence Score
0.65
Potential Side Effects
Lubricin Peptide discussions
Quick Facts
- Administration
- Intra-articular injection by physician
- Typical Dose
- Research/clinical trial doses: 3-9 mg intra-articular injection
- Frequency
- Monthly intra-articular injections in trial protocols
- References
- 0 curated + 48 from PubMed
- Clinical Trials
- 13 registered
- Evidence Score
- 0.6 / 100
Frequently Asked Questions about Lubricin Peptide
What is Lubricin Peptide?
Lubricin (Proteoglycan 4 PRG4) is a glycoprotein secreted by chondrocytes and synoviocytes that forms a protective boundary lubricant layer on articular cartilage surfaces. It is the primary molecule responsible for cartilage-on-cartilage lubrication in joints and its deficiency — as seen in camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome — results in severe early-onset arthritis demonstrating its essential role in joint protection. Recombinant lubricin (rhPRG4) is in clinical trials for OA and dry eye disease making it one of the most targeted joint lubrication therapeutics in development.
How does Lubricin Peptide work?
Lubricin acts as a boundary lubricant adsorbing to cartilage surfaces through electrostatic and hydrophobic interactions creating a thin protective film that reduces friction at the cartilage-cartilage interface. This boundary lubrication is particularly important at low sliding speeds and high loads where fluid film lubrication breaks down. Without adequate lubricin cartilage surfaces experience increased friction leading to surface damage cell death and progressive OA. Lubricin also prevents synovial cell overgrowth (pannus formation) and has anti-inflammatory effects in the joint space. Recombinant lubricin intra-articular injection in animal OA models has shown significant protection against cartilage damage and lubricin is considered a promising disease-modifying OA therapy.
What is the recommended dosage for Lubricin Peptide?
The typical dose is Research/clinical trial doses: 3-9 mg intra-articular injection. Monthly intra-articular injections in trial protocols. Administration: Intra-articular injection by physician. Recombinant lubricin (rhPRG4) is in Phase 2 clinical trials for knee OA. Not commercially available for OA. FDA-approved as OcuLieve for dry eye disease (different indication). This entry documents its research significance for joint lubrication.
What are the side effects of Lubricin Peptide?
Generally well tolerated in trials. Injection site reactions (common with intra-articular injection). Joint effusion (uncommon). Limited long-term safety data
What is the Lubricin Peptide cycle protocol?
Lubricin Peptide is typically cycled monthly. Single intra-articular injection monthly; Phase 2 trial protocol
Questions reflect common community inquiries. This is not medical advice.